This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Asselin-Labat, M.-L. Articles by Pallardy, M. Search for Related Content PubMed PubMed Citation Articles by Asselin-Labat, M.-L. Articles by Pallardy, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB DEXAMETHASONE Medline Plus Health Information Steroids

FoxO3 Mediates Antagonistic Effects of Glucocorticoids and Interleukin-2 on Glucocorticoid-Induced Leucine Zipper Expression

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 461 (M.-L.A.-L., A.B.-V., S.K., J.B., M.P.), Faculté de Pharmacie Paris-XI, 92296 Chamacr;tenay-Malabry, France; and INSERM, Unité 478 (M.L.), Faculté de Médecine X. Bichat, 75870 Paris, France

Address all correspondence and requests for reprints to: Marc Pallardy, Institut National de la Santé et de la Recherche Médicale, Unité 461, Faculté de Pharmacie Paris XI, 5 rue Jean-Baptiste Clément, 92296 Chtenay-Malabry Cedex, France. E-mail: marc.pallardy{at}cep.u-psud.fr.

We have analyzed the promoter of human gilz (glucocorticoid-induced leucine zipper), a dexamethasone-inducible gene that is involved in regulating apoptosis, and identified six glucocorticoid (GC)-responsive elements and three Forkhead responsive elements (FHREs). Promoter deletion analysis and point mutations showed that individual mutation of the GC-responsive elements does not affect GC-induced transcription and that FHRE-1 and FHRE-3 elements contribute to the effects of GCs. Furthermore, overexpression of the Forkhead transcription factor FoxO3 enhances GC-induced gilz mRNA expression. The functional significance of the interaction between FoxO3 and GC receptor was established in T lymphocytes. Indeed, we show that GCs failed to induce GILZ expression in the presence of IL-2, a cytokine known to antagonize GC effects in T cells. Using a constitutive active mutant of protein kinase B that inactivates FoxO3 or a FoxO3 mutant that cannot be inactivated by protein kinase B, we demonstrate that IL-2 inhibitory effects on GILZ expression are mediated through inhibition of FoxO3 transcriptional activity. Therefore, FoxO3 appears to be a key factor mediating GC and IL-2 antagonism for gilz regulation in T lymphocytes. This regulation of GILZ expression was placed in a meaningful context in evaluating the effects of GILZ on GC-induced apoptosis in T lymphocytes.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR

Ligands:   Dexamethasone

This article has been cited by other articles:

				E. Ayroldi and C. Riccardi Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action FASEB J, November 1, 2009; 23(11): 3649 - 3658. [Abstract] [Full Text] [PDF]

				Y. H. Yang, D. Aeberli, A. Dacumos, J. R. Xue, and E. F. Morand Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper J. Immunol., July 15, 2009; 183(2): 1435 - 1445. [Abstract] [Full Text] [PDF]

				T. J. Creed, R. W. Lee, P. V. Newcomb, A. J. di Mambro, M. Raju, and C. M. Dayan The Effects of Cytokines on Suppression of Lymphocyte Proliferation by Dexamethasone J. Immunol., July 1, 2009; 183(1): 164 - 171. [Abstract] [Full Text] [PDF]

				L. E Ellestad, S. A Malkiewicz, H D. Guthrie, G. R Welch, and T. E Porter Expression and regulation of glucocorticoid-induced leucine zipper in the developing anterior pituitary gland J. Mol. Endocrinol., February 1, 2009; 42(2): 171 - 183. [Abstract] [Full Text] [PDF]

				J. Zhou, R. H. Oakley, and J. A. Cidlowski DAX-1 (Dosage-Sensitive Sex Reversal-Adrenal Hypoplasia Congenita Critical Region on the X-Chromosome, Gene 1) Selectively Inhibits Transactivation But Not Transrepression Mediated by the Glucocorticoid Receptor in a LXXLL-Dependent Manner Mol. Endocrinol., July 1, 2008; 22(7): 1521 - 1534. [Abstract] [Full Text] [PDF]

				R. Soundararajan, J. Wang, D. Melters, and D. Pearce Differential Activities of Glucocorticoid-induced Leucine Zipper Protein Isoforms J. Biol. Chem., December 14, 2007; 282(50): 36303 - 36313. [Abstract] [Full Text] [PDF]

				R. W. J. Lee, T. J. Creed, L. P. Schewitz, P. V. Newcomb, L. B. Nicholson, A. D. Dick, and C. M. Dayan CD4+CD25int T Cells in Inflammatory Diseases Refractory to Treatment with Glucocorticoids J. Immunol., December 1, 2007; 179(11): 7941 - 7948. [Abstract] [Full Text] [PDF]

				W. Chen, I. Rogatsky, and M. J. Garabedian MED14 and MED1 Differentially Regulate Target-Specific Gene Activation by the Glucocorticoid Receptor Mol. Endocrinol., March 1, 2006; 20(3): 560 - 572. [Abstract] [Full Text] [PDF]